Indications and Purposes
| Indications And Usage Zaleplon Is Indicated For The Short-Term Treatment Of Insomnia. Zaleplon Has Been Shown To Decrease The Time To Sleep Onset For Up To 30 Days In Controlled Clinical Studies (See Clinical Trials Under Clinical Pharmacology ) . It Has Not Been Shown To Increase Total Sleep Time Or Decrease The Number Of Awakenings. The Clinical Trials Performed In Support Of Efficacy Ranged From A Single Night To 5 Weeks In Duration. The Final Formal Assessments Of Sleep Latency Were Performed At The End Of Treatment. |
All Formulated Excipients (0 Total)
None